Filters
A short-course antibiotic treatment for children with community-acquired pneumonia (CAP) demonstrates effectiveness similar to the long-course regimen but with fewer serious adverse events (AEs), reports a study.
Treatment with either ceftazidime-avibactam (CAZ/AVI) or ceftolozane-tazobactam (C/T) is well tolerated and effective in children infected with Gram-negative pathogens resistant to carbapenems, a recent study has shown.
Influenza vaccination in pregnant women, especially during the second or third trimester, cuts the risk of infection in infants, as shown in a study.
Acute respiratory infections (ARIs) are associated with various symptoms across different age groups, according to a Korea study.
Screening for anal cancer among men who have sex with men (MSM) with HIV aged ≥35 years is cost-effective, according to a recent study. However, there is a need for value-based prioritization strategies to improve screening use.
A recent study in Norway has recommended the use of faecal microbiota transplantation (FMT) as a first-line treatment to patients with primary Clostridioides difficile infection (CDI).
Hospital isolation for COVID-19 caused heightened anxiety in families, particularly children, during the early phase of the pandemic, according to a Singapore study.
In the treatment of adults with acute, uncomplicated influenza infections, onradivir appears to provide similar curative efficacy as oseltamivir while having an acceptable safety profile, as shown in a phase III study.
The bispecific antibody gremubamab, which targets two proteins on the surface of Pseudomonas aeruginosa, has been shown to substantially reduce bacterial load and improve quality of life for infected bronchiectasis patients in the phase II GREAT-2 study.
The investigational influenza–COVID-19 combination vaccine mRNA-1083 has demonstrated noninferiority to recommended standard-care flu and COVID-19 vaccines, with higher immune responses and an acceptable safety profile in adults at least 50 years of age, according to the results of a phase III trial.
